In many cancer types, the anti-VEGF resistant tumors present increased expression of FGF and/or FGFR upon hypoxia [45,46] that contributes for the synergistic cooperation of FGF/FGFR and VEFG/VEGFR axes to the amplification of tumor angiogenesis [25]. Here, VEGFA is linked to neoplasm.